Current sensitivity of Streptococcus pyogenes responsible for tonsillopharyngitis in France;Sensibilité actuelle en France de Streptococcus pyogenes responsable d'angine aiguë

Presse Medicale

Volumn 33, Issue 11, 2004, Pages 703-706

  Mariani Kurkdjian, Patricia ^a   Doit, C ^a   Deforche, D ^a   Brahimi, N ^a   Francois, M ^a   Van Den Abbeele, T ^a   Bingen, E ^a  

^a HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEFACLOR; CEFPODOXIME; CEFUROXIME; CLARITHROMYCIN; CLINDAMYCIN; ERYTHROMYCIN; PENICILLIN G;

AGAR GEL DIFFUSION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; DIAGNOSTIC TEST; DRUG ACTIVITY; ERADICATION THERAPY; ERMA GENE; ERMB GENE; GENETIC VARIABILITY; IN VITRO STUDY; MACROLIDE RESISTANCE GENE; MEF GENE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHARYNGITIS; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; STREPTOCOCCUS GROUP A; STREPTOCOCCUS PYOGENES; TONSILLITIS; TREATMENT FAILURE;

EID: 3042701783     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0755-4982(04)98724-6     Document Type: Article

References (27)

1. Bingen E, Lambert-Zechovsky N, Mariani-Kurkdjian P, Aujard Y, Mathieu H. Le concept de pathogénie indirecte cause d'échec de certains traitements antibiotiques. La Semaine des Hôpitaux de Paris 1989; 65:1072-8.
2. Sauzeau C, Bingen E, Lambert-Zechovsky N, Mariani-Kurkdjian P. Analyse des causes d'échec de l'éradication du Streptocoque A dans l'angine. Le Pédiatre 1987; No 106, 247-9.
3. Osterlund A, Popa R, Nikkila T, Scheynius A, Engstrand L Intracellular reservoir of Streptococcus pyogenes in vivo: a possible explanation for recurrent pharyngotonsillitis. Laryngoscope 1997;107:640-7.
4. Falck G, Grahn-Hakansson E, Holm SE, Roos K, Lagergren L Tolerance and efficacy of interfering alpha-streptococci in recurrence of streptococcal pharyngotonsillitis: a placebo-controlled study. Acta Otolaryngol 1999;119:944-8.
5. Bingen E, Denamur E, Lambert-Zechovsky N, Braimi N, el Lakany M, Elion J. DNA restriction fragment length polymorphism differentiates recurrence from relapse in treatment failures of Streptococcus pyogenes pharyngitis. J Med Microbiol 1992;37:162-4.
6. Conley J, Olson ME, Cook LS, Ceri H, Phan V, Davies HD. Biofilm formation by group a streptococci: is there a relationship with treatment failure? J Clin Microbiol 2003;41:4043-8.
7. Turkheim H. Antibiothérapie par voie générale en pratique courante: angine - Afssaps, Décembre 2002. Arch Pédiatr 2003; 10: 260-71.
8. Bingen E, Fitoussi F, Doit C et al. Resistance to macrolides in Streptococcus pyogenes in France in pediatric patients. Antimicrob Agents Chemother 2000; 44: 1453-7.
9. Portier H, Bourrillon A, Lucht F, Choutet P, Gehanno P, Meziane L, Bingen E. Traitement des angines aiguës à streptocoque β-hémolytique du groupe A chez l'enfant par la josamycine pendant 5 jours. Arch Pediatr 2001; 8: 700-6.
10. Perez-Trallero E, Urbieta M, Montes M, Ayestaran I, Marimon JM. Emergence of Streptococcus pyogenes strains resistant to erythromycin in Gipuzkoa, Spain. Eur J Clin Microbiol Infect Dis 1998; 17: 25-31.
11. CornagliaG, Ligozzi M, Mazzariol A et al. Resistance of Streptococcus pyogenes to erythromycin and related antibiotics in Italy. Clin Infect Dis 1998; 27: 587-592.
12. Members of the SFM Antibiogram Committee. Comite de l'antibiogramme de la Société francaise de microbiologie, report 2003. Int J Antimicrob Agents 2003;21:364-91.
13. NCCLS. Performance standards for antimicrobial disk susceptibility tests. 7 ed Wayne, Pa: NCCLS, 2003 Approved standard M2-A7.
14. Klugman KP, Capper T, Widdowson CA et al. Increased activity of 16-membered lactone ring macrolides against erythromycin resistant Streptococcus pyogenes and Streptococcus pneumoniae: characterization of South African isolates. J Antimicrob Chemother 1998; 42: 729-34.
15. Seppàla H, Skurnik M, Soini H et al. A novel erythromycin resistance methylase gene (ermTR) in Streptococcus pyogenes. Antimicrob Agents Chemother 1998; 42: 257-62.
16. Azavedo de JCS, Yeung RH, Bast DJ et al. Prevalence and mechanisms of macrolides resistance in clinical isolates of group A Streptococci from Ontario, Canada. Antimicrob Agents Chemother 1999; 43: 2144-7.
17. Clewell DB, Franke AE. Characterization of a plasmid determining resistance to erythromycin, lincomycin, and vernamycin B in a strain of Streptococcus pyogenes. Antimicrob Agents Chemother 1974; 5: 534-7.
18. Sutcliffe J, Grebe T, Tait-Kamradt A et al. Detection of erythromycin-resistant determinants by PCR. Antimicrob Agents Chemother 1996; 40: 2562-6.
19. Tenover FC, Arbeit RD, Goering RV et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33: 2233-9.
20. Borzani M, De Luca M, Varotto F. A survey of susceptibility to erythromycin amongst Streptococcus pyogenes isolates in Italy. J Antimicrob Chemother 1997; 40: 457-8.
21. Giovanetti E, Montanari MP, Mingoia NI et al. Phenotypes and genotypes of erythromycin-resistant Streptococcus pyogenes strains in Italy and heterogeneity of inducible resistant strains. Antimicrob Agents Chemother 1999; 43: 1935-40.
22. Perez-Trallero EJ, Marimon M, Montes JM et al. Clonal differences among erythromycin-resistant Streptococcus pyogenes in Spain. Emerging Infect Dis 1999; 3: 235-40.
23. Garcia-Bermejo I, Cacho J, Orden B, Alos JI, Gomez-Garces JL. Emergence of erythromycin-resistant, clindamycin-susceptible Streptococcus pyogenes isolates in Madrid, Spain. Antimicrob Agents Chemother 1998; 42: 989-90.
24. Martin JM, Green M, Barbadora KA, Wald ER. Erythromycin-resistant group A streptococci in schoolchildren in Pittsburgh. N Engl J Med 2002; 346: 1200-6.
25. Bert F, Branger C, Lambert-Zechovsky N. Pulsed-field gel electrophoresis is more discriminating than multilocus enzyme electrophoresis and random amplified polymorphic DNA analysis for typing pyogenic streptococci. Curr Microbiol 1997; 34: 226-9.
26. Seppala H, Nissinen A, Jarvinen H et al. Resistance to erythromycin in group A streptococd. N Engl J Med 1992; 326: 292-7.
27. Varaldo PE, Debbia EA, Nicoletti G, Pavesio D, Ripa S, Schito GC, Tempera G. Nationwide survey in Italy of treatment of Streptococcus pyogenes pharyngitis in children: influence of macrolide resistance on clinical and microbiological outcomes. Artemis-Italy Study Group. Clin Infect Dis 1999; 29: 869-73.